On October 4, 2023, Arthur, an analyst from HC Wainwright & Co., expressed his positive outlook on Adagene (NASDAQ:ADAG) by reaffirming his Buy rating and maintaining a price target of $5. His belief in the stock‘s undervaluation suggests that there is potential for its price to increase up to $5. Arthur’s assessment of Adagene’s financial performance, growth prospects, and various other factors contribute to his favorable rating. It is worth noting that two other analysts have also assigned a Buy rating to Adagene, aligning with the overall consensus.
https://beststocks.com/analyst-reaffirms-positive-outlook-on-adagene/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.